Related Experiment Video
Updated: Mar 30, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
PPARα induces cell apoptosis by destructing Bcl2
Jiaming Gao1,2, Qian Liu1, Ying Xu2
1Department of Oncology, The Affiliated Wujin People's Hospital, Jiangsu University, Changzhou, Jiangsu Province, China.
Abstract:
PPARα belongs to the peroxisome-proliferator-activated receptors (PPARs) family, which plays a critical role in inhibiting cell proliferation and tumorigenesis, while the molecular mechanism is still unclear. Here we report that PPARα serves as an E3 ubiquitin ligase to govern Bcl2 protein stability. PPARα physically bound to Bcl2 protein. In this process, PPARα/C102 was critical for PPARα binding to BH3 domain of Bcl2, subsequently, PPARα transferred K48-linked polyubiquitin to lysine-22 site of Bcl2 resulting in its ubiquitination and proteasome-dependent degradation. Importantly, overexpression of PPARα enhanced cancer cell chemotherapy sensitivity. In contrast, silenced PPARα decreased this event. These findings revealed a novel mechanism of PPARα governed endogenous Bcl2 protein stability leading to reduced cancer cell chemoresistance, which provides a potential drug target for cancer treatment.
Insights
Peroxisome-proliferator-activated receptors alpha (PPARα) acts as an E3 ubiquitin ligase, degrading the Bcl2 protein. This mechanism enhances cancer cell sensitivity to chemotherapy, offering a new therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Peroxisome-proliferator-activated receptors (PPARs) are crucial in regulating cell proliferation and tumorigenesis.
- The precise molecular mechanisms underlying PPARs' role in cancer are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanism by which PPARα influences cancer cell proliferation and chemoresistance.
- To investigate the role of PPARα in regulating Bcl2 protein stability.
Main Methods:
- Co-immunoprecipitation assays to confirm physical binding between PPARα and Bcl2.
- Ubiquitination assays to detect K48-linked polyubiquitination of Bcl2 at lysine-22.
- Cellular experiments involving PPARα overexpression and silencing to assess chemotherapy sensitivity.
Main Results:
- PPARα directly binds to the BH3 domain of Bcl2.
- PPARα functions as an E3 ubiquitin ligase, mediating K48-linked polyubiquitination and proteasomal degradation of Bcl2.
- Overexpression of PPARα increases cancer cell sensitivity to chemotherapy, while silencing PPARα reduces it.
Conclusions:
- PPARα regulates Bcl2 protein stability through ubiquitination and proteasomal degradation.
- This novel mechanism contributes to reduced cancer cell chemoresistance.
- PPARα represents a potential therapeutic target for enhancing cancer treatment efficacy.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
06:12Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Abnormal Proliferation
Apoptosis
Cell Specific Gene Expression
Negative Regulator Molecules